Is ARTL or ASND more undervalued in 2026?

CirclFi compares Artelo Biosciences, Inc. (ARTL) and Ascendis Pharma A/S (ASND) using 13 institutional-grade valuation models. ARTL has a Quality of Company score of 3.9/10 while ASND scores 5.9/10.

Which is a better buy — ARTL or ASND?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do ARTL and ASND valuations compare?

ARTL at $1.40 and ASND at $224.11 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

ARTL vs ASND Valuation Comparison 2026 — Intrinsic Value Analysis

ARTL

Pharmaceutical Preparations

Artelo Biosciences, Inc.

Quality

3.9

out of 10

Value Trap

SAFE

Price

$1.40

Last close

Models

7/13

Active

ASND

Pharmaceutical Preparations

Ascendis Pharma A/S

Quality

5.9

out of 10

Value Trap

SAFE

Price

$224.11

Last close

Models

12/13

Active

Model-by-Model Comparison

Model	Type	ARTL Fair Value	ARTL Upside	ASND Fair Value	ASND Upside
Bayesian DCF	Intrinsic	$2.59	+84.7%	$72.57	-67.6%
Earnings Power Value	Intrinsic	—	—	$7.22	-96.7%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$3.99	+184.8%	—	—
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for ARTL vs ASND — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

ARTL vs ASND — Which Stock Is More Undervalued?

ASND scores higher with a 5.9/10 quality rating vs ARTL's 3.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Artelo Biosciences, Inc. (ARTL) and Ascendis Pharma A/S (ASND) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

ARTL currently trades at $1.40 with a QOC of 3.9/10, while ASND trades at $224.11 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).